$109.00
CJC-1295 Without DAC + Ipamorelin 10mg is a 1:1 blended research peptide, typically containing 5mg Modified GRF 1-29 and 5mg Ipamorelin, studied for GHRH/GHS-R signalling and growth-hormone-axis research. For laboratory research use only.
CJC-1295 Without DAC + Ipamorelin 10mg is a blended research peptide combination, typically supplied as 5mg CJC-1295 Without DAC + 5mg Ipamorelin per vial. CJC-1295 Without DAC, also known as Modified GRF 1-29, is a synthetic GHRH analogue studied for GHRH receptor activity and pulsatile growth hormone release models. Ipamorelin is a selective growth hormone secretagogue peptide studied for ghrelin receptor / GHS-R1a signalling, pituitary response pathways, and neuroendocrine research. Together, this blend is commonly used in laboratory studies involving growth-hormone-axis signalling and paired GHRH/GHRP research models.
CAS No.:
CJC-1295 Without DAC / Modified GRF 1-29: 863288-34-0
Ipamorelin: 170851-70-4
This product is intended for laboratory research use only and is not for human consumption, clinical use, veterinary use, or diagnostic applications.
